Sign In
Last checked at 
5 Mar 2012 12:17
ο»Ώ
Β
Β
Craneware plc
("Craneware" or the "Company")
Β
Total Voting Rights
Β
In accordance with the FSA Disclosure and Transparency Rules, Craneware announces that at the date of this notice its issued share capital comprises 26,978,823 ordinary shares of 1p ("Ordinary Shares") each with voting rights.
Β
No Ordinary Shares are held in treasury.
Β
The total voting rights in the Company is therefore 26,978,823. The voting rights of all of the Ordinary Shares are identical.
Β
The figure above may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Craneware, under the FSA Disclosure and Transparency Rules.
Β
Β
For further information, please contact:
Β
Craneware plc | Peel Hunt | Newgate Threadneedle |
+44 (0)131 550 3100 | +44 (0)20 7418 8900 | +44 (0)20 7653 9850 |
Keith Neilson, CEO | Dan Webster | Caroline Evans-Jones |
Craig Preston, CFO | Richard Kauffer | Fiona Conroy |
Β
About Craneware
Β
Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta, Boston, Nashville and Scottsdale employing over 200 staff. Craneware is the leader in automated revenue integrity solutions that improve financial performance for healthcare organisations. Craneware's market-driven, SaaS solutions help hospitals and other healthcare providers more effectively price, charge, code and retain earned revenue for patient care services and supplies. This optimises reimbursement, increases operational efficiency and minimises compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com and stoptheleakage.com
Β
Β
Β
Follow the stocks
